Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Non Operating Income of -$20.7 million for Q4 2025, down 75.11% year-over-year from -$83.1 million in Q4 2024, and down 96.23% quarter-over-quarter from -$10.5 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Non Operating Income history runs 16 years deep, the most recent figure standing at -$20.7 million for Q4 2025.
- In Q4 2025, Non Operating Income fell 75.11% year-over-year to -$20.7 million; the TTM figure through Dec 2025 stood at -$55.7 million (down 5.13% YoY), while the FY2025 annual figure was -$52.6 million, up 20.81% from the prior year.
- Non Operating Income for Q4 2025 stood at -$20.7 million, down from -$10.5 million in the prior quarter.
- The five-year high for Non Operating Income was -$10.0 million in Q2 2025, with the low at -$30.6 million in Q1 2021.
- The 5-year median for Non Operating Income is -$16.5 million (2022), against an average of -$16.5 million.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income soared 46.15% in 2022, then plunged 75.11% in 2025.
- Prestige Consumer Healthcare's Non Operating Income stood at -$17.1 million in 2021, then retreated by 11.5% to -$19.1 million in 2022, then climbed by 9.49% to -$17.3 million in 2023, then soared by 31.58% to -$11.8 million in 2024, then slumped by 75.11% to -$20.7 million in 2025.
- Business Quant data shows PBH's Non Operating Income at -$20.7 million in Q4 2025, -$10.5 million in Q3 2025, and -$10.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.68 Mn |
| Sep 30, 2025 | -10.54 Mn |
| Jun 30, 2025 | -9.98 Mn |
| Mar 31, 2025 | -14.47 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | -14.83 Mn |
| Dec 31, 2023 | -17.26 Mn |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | -16.48 Mn |
| Mar 31, 2023 | -18.53 Mn |
| Dec 31, 2022 | -19.07 Mn |
| Sep 30, 2022 | -17.79 Mn |
| Jun 30, 2022 | -16.12 Mn |
| Mar 31, 2022 | -16.46 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Sep 30, 2021 | -18.93 Mn |
| Jun 30, 2021 | -14.97 Mn |
| Mar 31, 2021 | -30.56 Mn |